Mirador Therapeutics Revenue and Competitors

USA

Location

$400M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Mirador Therapeutics's estimated annual revenue is currently $12.6M per year.(i)
  • Mirador Therapeutics's estimated revenue per employee is $155,000
  • Mirador Therapeutics's total funding is $400M.

Employee Data

  • Mirador Therapeutics has 81 Employees.(i)
  • Mirador Therapeutics grew their employee count by 252% last year.

Mirador Therapeutics's People

NameTitleEmail/Phone
1
Founder, Chairman & CEOReveal Email/Phone
2
Chairman and CEOReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
Chief People OfficerReveal Email/Phone
6
Chief Accounting OfficerReveal Email/Phone
7
Chief Scientific OfficerReveal Email/Phone
8
Chief Medical OfficerReveal Email/Phone
9
Chief Strategy OfficerReveal Email/Phone
10
Chief Legal OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$9.1M59-9%N/AN/A
#10
$16.6M1073%N/AN/A
Add Company

What Is Mirador Therapeutics?

Mirador is a next-generation precision medicine company focused on immunology and inflammation. The company’s Mirador360 TM precision development engine leverages the latest advances in human genetics and cutting-edge data science to rapidly advance new precision medicines for patients living with chronic immune-mediated inflammatory and fibrotic diseases. Launched in 2024, Mirador has raised over $400 million from leading life sciences investors and is based in San Diego, CA.

keywords:N/A

$400M

Total Funding

81

Number of Employees

$12.6M

Revenue (est)

252%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.9M8111%N/A
#2
$16.3M81-2%N/A
#3
$21.9M8113%N/A
#4
$8.3M8116%N/A
#5
$14.6M8111%N/A